Sign In
Buy AKRO
$54.65
+0 (+0%)
At Close: Mar 06, 2026
GENFIT : la technologie NIS4 objet d’une publication dans The Lancet Gastroenterology
07:15am, Wednesday, 05'th Aug 2020
(AOF) - Genfit annonce que les données décrivant la dérivation et la validation de NIS4 ont été acceptées pour publication dans The Lancet Gastroenterology & Hepatology. NIS4 est la technolo
GENFIT : la technologie NIS4 objet d’une publication dans The Lancet Gastroenterology | Zone bourse
07:05am, Wednesday, 05'th Aug 2020Enanta Pharmaceuticals Inc (ENTA) Q3 2020 Earnings Call Transcript | The Motley Fool
05:31am, Wednesday, 05'th Aug 2020
ENTA earnings call for the period ending June 30, 2020.
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Merck, Hanmi sign $870M deal for NASH drug
05:43pm, Tuesday, 04'th Aug 2020
Hanmi will retain options for the drug, efinopegdutide, in Korea under the deal, in which Merck is paying the Seoul-based company $10 million upfront and up to $860 for development, regulatory and com
Durect Corp (DRRX) Q2 2020 Earnings Call Transcript | The Motley Fool
05:00am, Tuesday, 04'th Aug 2020
DRRX earnings call for the period ending June 30, 2020.
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for NASH
INVEST Pitch Perfect winner spotlight: Pleiogenix eyes road ahead for liver disease drug
04:21pm, Monday, 03'rd Aug 2020
The company is hoping to close its seed funding round in the next six months and aims to be in a position to seek regulatory approval for its lead asset, PLX888, in acute alcoholic hepatitis in 2023.
Enanta Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference 2020
12:00am, Monday, 03'rd Aug 2020
Enanta Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference 2020
3 “Perfect 10” Stocks To Consider During Uncertain Times
12:00am, Thursday, 30'th Jul 2020
Stocks Analysis by Investing Insights covering: Arrowhead Pharmaceuticals Inc, LKQ Corporation, Dropbox Inc. Read Investing Insights 's latest article on Investing.com
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
12:00am, Monday, 27'th Jul 2020
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
French biotech Genfit shifts gears after Phase III NASH failure
06:02pm, Thursday, 23'rd Jul 2020
The company said it was formally terminating the Phase III study of the drug elafibranor in NASH and refocus its development of the drug on another disease, primary biliary cholangitis, as well as a d
Xconomy: FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC
04:55pm, Thursday, 23'rd Jul 2020
The FDA has lifted a hold on clinical trials for an experimental CymaBay Therapeutics drug in three liver diseases, clearing the way for tests to resume
